enGene Holdings is trading at $1.66, up 6.09%, with biotech-sector strength the clearest available context.
- XBI is up 2.20% during regular trading.
- No clear company-specific catalyst has been identified. enGene announced an October 15 KOL webinar on October 13, but the announcement does not establish that it caused the move.
- The broader market picture is mixed, making sector performance the likeliest explanation.